Skip to the page

Data / Drug companies / Dr. Reddy's Laboratories Inc.

Dr. Reddy's Laboratories Inc.: 416 products in the FDA NDC directory, labeler code 43598

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Dr. Reddy's Laboratories Inc. (labeler code 43598) lists 416 products in the FDA National Drug Code Directory, covering 152 finished drugs by generic name. By type: 327 prescription drugs, 66 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 5, 2026.

The request: Watch Dr. Reddy's Laboratories Inc. (FDA labeler code 43598): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
43598
Products in commercial distribution
416
Packages
874
Finished drugs by generic name
152
Prescription products
327
Over the counter products
66
Controlled substance products
Schedule II 2, Schedule III 5, Schedule IV 6, Schedule V 9
Flagged as original packager
358 of 358 products that carry the flag
Started marketing in the last 12 months
30
Products with a marketing end date set
11
Earliest marketing start
May 4, 2011
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)37991.1%
Drugs for further processing235.5%
New drug applications (NDA)81.9%
Authorized generics (NDA)61.4%

Products by type

TypeProductsShare
Prescription drugs32778.6%
Over the counter drugs6615.9%
Drugs for further processing215%
Bulk ingredients20.5%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Aripiprazole1249
Amlodipine besylate and atorvastatin calcium111
Nicotine polacrilex1057
Bupropion hydrochloride967
Naproxen sodium9100
Atorvastatin calcium859
Pregabalin854
Esomeprazole magnesium877
Nitroglycerin740
Deferasirox621
Levetiracetam injection61
Lenalidomide619
Dasatinib618
Lurasidone hydrochloride528
Docetaxel521
Tadalafil554
Guaifenesin and dextromethorphan hbr426
Treprostinil46
Eslicarbazepine acetate410
Olopatadine hydrochloride ophthalmic416
Carboprost tromethamine422
Topiramate456
Varenicline tartrate423
Fluphenazine hydrochloride429
Hydroxychloroquine sulfate433
Nicotine437
Lamotrigine451
Buprenorphine and naloxone422
Phentermine and topiramate extended-release41
Chlorthalidone442
Methylprednisolone sodium succinate414
Triamcinolone acetonide477
Eltrombopag411
Guaifenesin4123
Zoledronic acid418
Pomalidomide412
Ezetimibe and simvastatin48
Sunitinib malate49
Venlafaxine hydrochloride348
Olanzapine349
Sacubitril and valsartan329
Prednisone349
Azacitidine320
Saxagliptin and metformin hydrochloride31
Dabigatran etexilate317
Nilotinib310
Sapropterin dihydrochloride310
Pemetrexed disodium314
Fosaprepitant310
Propofol injectable emulsion31
Loratadine3125
Famotidine3138
Lubiprostone220
Icosapent ethyl221
Phytonadione231
Abiraterone acetate222
Vigabatrin218
Levocetirizine dihydrochloride252
Diclofenac sodium topical gel, 1%215
Fenofibrate256
Chlorpromazine hci22
Fesoterodine fumarate212
Pralatrexate23
Sevelamer carbonate for oral suspension21
Darunavir214
Levoleucovorin25
Fexofenadine hydrochloride265
Omeprazole and sodium bicarbonate211
Lansoprazole258
Cinacalcet218
Daptomycin225
Omeprazole2106
Diazepam251
Tetrabenazine212
Aripiprazole orally disintegrating22
Amphetamine sulfate tablets22
Desmopressin acetate227
Nintedanib211
Phenylephrine hydrochloride277
Cetirizine hydrochloride tablets28
Doxycycline263
Neostigmine22
Ticagrelor232
Potassium chloride284
Dimethyl fumarate220
Sugammadex222
Ziprasidone mesylate29
Clopidogrel bisulfate231
Thiotepa28
Docosanol242
Progesterone239
Dexmedetomidine hydrochloride221
Enalaprilat23
Venlafaxine233
Ciprofloxacin and dexamethasone112
Valganciclovir hydrochloride111
Melphalan hydrochloride114
Raloxifene hydrochloride116
Ephedrine sulfate126
Formoterol fumarate17

Dosage forms

Dosage formProductsShare
Tablet, film coated6515.6%
Tablet6315.1%
Capsule4410.6%
Injection, solution348.2%
Injection307.2%
Tablet, extended release204.8%
Injection, powder, lyophilized, for solution194.6%
Lozenge184.3%
Capsule, delayed release153.6%
Tablet, film coated, extended release112.6%
Tablet, coated102.4%
Solution81.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Phytonadione43598-032Injection, emulsionGeneric drugs (ANDA)October 5, 2026
Docosanol43598-946CreamGeneric drugs (ANDA)October 1, 2026
Docosanol43598-044CreamGeneric drugs (ANDA)September 23, 2026
Pomalidomide43598-520CapsuleGeneric drugs (ANDA)August 31, 2026
Pomalidomide43598-519CapsuleGeneric drugs (ANDA)August 31, 2026
Pomalidomide43598-518CapsuleGeneric drugs (ANDA)August 31, 2026
Pomalidomide43598-517CapsuleGeneric drugs (ANDA)August 31, 2026
Permethrin43598-481CreamGeneric drugs (ANDA)August 26, 2026
Prednisone delayed release43598-888Tablet, delayed releaseGeneric drugs (ANDA)August 12, 2026
Sugammadex43598-925Injection, solutionGeneric drugs (ANDA)July 28, 2026
Sugammadex43598-924Injection, solutionGeneric drugs (ANDA)July 28, 2026
Nintedanib43598-148CapsuleGeneric drugs (ANDA)April 2, 2026
Nintedanib43598-147CapsuleGeneric drugs (ANDA)April 2, 2026
Eltrombopag43598-732Tablet, film coatedGeneric drugs (ANDA)March 17, 2026
Eltrombopag43598-731Tablet, film coatedGeneric drugs (ANDA)March 17, 2026
Eltrombopag43598-730Tablet, film coatedGeneric drugs (ANDA)March 17, 2026
Eltrombopag43598-151Tablet, film coatedGeneric drugs (ANDA)March 17, 2026
Pralatrexate43598-343InjectionGeneric drugs (ANDA)March 4, 2026
Pralatrexate43598-342InjectionGeneric drugs (ANDA)March 4, 2026
Fosaprepitant43598-671Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)February 12, 2026
Topiramate43598-942Capsule, extended releaseGeneric drugs (ANDA)February 1, 2026
Topiramate43598-941Capsule, extended releaseGeneric drugs (ANDA)February 1, 2026
Topiramate43598-940Capsule, extended releaseGeneric drugs (ANDA)February 1, 2026
Topiramate43598-939Capsule, extended releaseGeneric drugs (ANDA)February 1, 2026
Eribulin Mesylate43598-125InjectionGeneric drugs (ANDA)January 22, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.